100000 - Document - Document And Entity Information link:presentationLink link:calculationLink link:definitionLink 100010 - Statement - Consolidated Balance Sheets link:presentationLink link:calculationLink link:definitionLink 100020 - Statement - Consolidated Balance Sheets (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 100030 - Statement - Consolidated Statements of Operations and Comprehensive Loss link:presentationLink link:calculationLink link:definitionLink 100040 - Statement - Consolidated Statements of Stockholders' Equity/(Deficit) link:presentationLink link:calculationLink link:definitionLink 100050 - Statement - Consolidated Statements of Cash Flows link:presentationLink link:calculationLink link:definitionLink 100060 - Disclosure - Cybersecurity Risk Management, Strategy and Governance link:presentationLink link:calculationLink link:definitionLink 995453 - Disclosure - Company and Nature of Business link:presentationLink link:calculationLink link:definitionLink 995463 - Disclosure - Summary of Significant Accounting Policies link:presentationLink link:calculationLink link:definitionLink 995473 - Disclosure - Balance Sheet Components link:presentationLink link:calculationLink link:definitionLink 995483 - Disclosure - Fair Value of Financial Measurements link:presentationLink link:calculationLink link:definitionLink 995493 - Disclosure - License and Services Agreement link:presentationLink link:calculationLink link:definitionLink 995503 - Disclosure - Collaboration Agreements link:presentationLink link:calculationLink link:definitionLink 995513 - Disclosure - Commitments and Contingencies link:presentationLink link:calculationLink link:definitionLink 995523 - Disclosure - Leases link:presentationLink link:calculationLink link:definitionLink 995533 - Disclosure - Debt link:presentationLink link:calculationLink link:definitionLink 995543 - Disclosure - Convertible Preferred Stock link:presentationLink link:calculationLink link:definitionLink 995553 - Disclosure - Warrants link:presentationLink link:calculationLink link:definitionLink 995563 - Disclosure - Convertible Debenture link:presentationLink link:calculationLink link:definitionLink 995573 - Disclosure - Common Stock Reserved For Issuance link:presentationLink link:calculationLink link:definitionLink 995583 - Disclosure - Stock-Based Compensation link:presentationLink link:calculationLink link:definitionLink 995593 - Disclosure - Income Taxes link:presentationLink link:calculationLink link:definitionLink 995603 - Disclosure - Net Loss Per Share Attributable to Common Stockholders link:presentationLink link:calculationLink link:definitionLink 995613 - Disclosure - Employee Benefit Plan link:presentationLink link:calculationLink link:definitionLink 995623 - Disclosure - Related Party Transactions link:presentationLink link:calculationLink link:definitionLink 995633 - Disclosure - Segment Information link:presentationLink link:calculationLink link:definitionLink 995643 - Disclosure - Restatement link:presentationLink link:calculationLink link:definitionLink 995653 - Disclosure - Subsequent Events link:presentationLink link:calculationLink link:definitionLink 995663 - Disclosure - Summary of Significant Accounting Policies (Policies) link:presentationLink link:calculationLink link:definitionLink 995673 - Disclosure - Summary of Significant Accounting Policies (Tables) link:presentationLink link:calculationLink link:definitionLink 995683 - Disclosure - Balance Sheet Components (Tables) link:presentationLink link:calculationLink link:definitionLink 995693 - Disclosure - Fair Value of Financial Measurements (Tables) link:presentationLink link:calculationLink link:definitionLink 995703 - Disclosure - Common Stock Reserved For Issuance (Tables) link:presentationLink link:calculationLink link:definitionLink 995713 - Disclosure - Stock-Based Compensation (Tables) link:presentationLink link:calculationLink link:definitionLink 995723 - Disclosure - Income Tax (Tables) link:presentationLink link:calculationLink link:definitionLink 995733 - Disclosure - Net Loss Per Share Attributable to Common Stockholders (Tables) link:presentationLink link:calculationLink link:definitionLink 995743 - Disclosure - Segment Information (Tables) link:presentationLink link:calculationLink link:definitionLink 995753 - Disclosure - Restatement (Tables) link:presentationLink link:calculationLink link:definitionLink 995763 - Disclosure - Company and Nature of Business - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 995773 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 995783 - Disclosure - Summary of Significant Accounting Policies - Summary of Estimated Useful Lives for Property and Equipment (Detail) link:presentationLink link:calculationLink link:definitionLink 995793 - Disclosure - Balance Sheet Components - Property and Equipment (Details) link:presentationLink link:calculationLink link:definitionLink 995803 - Disclosure - Balance Sheet Components - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 995813 - Disclosure - Balance Sheet Components - Schedule of Accrued Expenses (Details) link:presentationLink link:calculationLink link:definitionLink 995823 - Disclosure - Fair Value of Financial Measurements - Summary of Fair Value of Financial Assets by Level within Fair Value Hierarchy (Details) link:presentationLink link:calculationLink link:definitionLink 995833 - Disclosure - Fair Value of Financial Measurements - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 995843 - Disclosure - Fair Value Measurements - Summary of Changes in Fair Value of Company's Warrant Liabilities that is Recognized in Change in Fair Value of Warrant Liabilities in Accompanying Statements of Operations and Comprehensive Loss (Details) link:presentationLink link:calculationLink link:definitionLink 995853 - Disclosure - Fair Value Measurements - Summary of Key Inputs into Valuation Models Used to Estimate Fair Value of Warrant Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 995863 - Disclosure - Fair Value Measurements - Schedule of Quantitative Information Regarding Measurement Inputs to Estimate the Fair Value of Asset (Details) link:presentationLink link:calculationLink link:definitionLink 995873 - Disclosure - Fair Value Measurements - Schedule of Changes in Derivative Assets (Details) link:presentationLink link:calculationLink link:definitionLink 995883 - Disclosure - License and Services Agreement - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 995893 - Disclosure - Collaboration Agreements - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 995903 - Disclosure - Commitments and Contingencies - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 995913 - Disclosure - Leases - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 995923 - Disclosure - Debt - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 995933 - Disclosure - Convertible Preferred Stock - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 995943 - Disclosure - Warrants - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 995953 - Disclosure - Convertible Debenture - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 995963 - Disclosure - Common Stock Reserved For Issuance - Common Stock Reserved For Potential Future Issuances (Details) link:presentationLink link:calculationLink link:definitionLink 995973 - Disclosure - Stock-Based Compensation - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 995983 - Disclosure - Stock-Based Compensation - Summary of Stock Option Activity and Related Information (Details) link:presentationLink link:calculationLink link:definitionLink 995993 - Disclosure - Stock-Based Compensation - Grant Date Fair Value of Employee Stock Options Estimated Using Black-Scholes Option-Pricing Model with Weighted-Average Assumptions (Details) link:presentationLink link:calculationLink link:definitionLink 996003 - Disclosure - Stock-Based Compensation - Total Stock-Based Compensation Expense Recognized in Consolidated Statements of Operations and Comprehensive Loss (Details) link:presentationLink link:calculationLink link:definitionLink 996013 - Disclosure - Income Taxes - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 996023 - Disclosure - Income Taxes - Schedule of Effective Income Tax Rate Reconciliation (Details) link:presentationLink link:calculationLink link:definitionLink 996033 - Disclosure - Income Taxes - Schedule of Deferred Tax Assets and Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 996043 - Disclosure - Net Loss Per Share Attributable to Common Stockholders - Weighted-Average Common Stock Equivalents Excluded from Calculation of Diluted Net Loss Per Share as They Had Anti-Dilutive Effect (Details) link:presentationLink link:calculationLink link:definitionLink 996053 - Disclosure - Employee Benefit Plan - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 996063 - Disclosure - Related Party Transactions - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 996073 - Disclosure - Segment Information - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 996083 - Disclosure - Segment Information - Summary of Disaggregated Research and Development Expenses (Details) link:presentationLink link:calculationLink link:definitionLink 996093 - Disclosure - Restatement - Summary of Effects of Restatement by Financial-Statement Line Item Affected (Details) link:presentationLink link:calculationLink link:definitionLink Effective Interest Method Effective Interest Method [Member] Effective interest method. Statement [Line Items] Statement [Line Items] Financial Liabilities: Liabilities, Fair Value Disclosure [Abstract] Cybersecurity Risk Board of Directors Oversight [Text Block] Accounts receivable Increase (Decrease) in Accounts Receivable Plan Name Plan Name [Domain] Preferred Stock, Convertible, Conversion Price Conversion price Warrants. Warrants TextBlock Warrants Entity Address, Postal Zip Code Entity Address, Postal Zip Code Cybersecurity Risk Board Committee or Subcommittee Responsible for Oversight [Text Block] Monthly rental payments Operating Lease Monthly Rental Payment Operating lease monthly rental payment. Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Table] Fair Value, Recurring and Nonrecurring [Table] Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Costs and expenses: Costs and Expenses [Abstract] Number of operating segments Number of Operating Segments Financial Instruments Subject to Mandatory Redemption, Settlement Terms, Share Value, Amount, Total Payments under mandatory redemption provision Financial Instruments Subject to Mandatory Redemption, Settlement Terms, Share Value, Amount Weighted-Average Exercise Price, Exercisable Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price Exchange of VX3 Units Exchange Of V X3 Units [Member] Exchange of VX3 units. Stockholders' Equity, Reverse Stock Split Reverse stock split description Balance, Shares Balance, Shares Shares, Outstanding Fair Value Hierarchy and NAV Fair Value Hierarchy and NAV [Axis] Auditor Name Auditor Name Principal Repayments Principal Repayments [Member] Principal repayments. Level 2 Fair Value, Inputs, Level 2 [Member] Share Based Compensation Arrangement By Share Based Payment Award [Line Items] Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Long-term Debt, Type Long-Term Debt, Type [Domain] Fees paid in connection with issuance of debentures Fees Paid In Connection With Issuance Of Debentures Fees paid in connection with issuance of debentures. Long-Term Debt, Current Maturities, Total Current portion of long-term debt Long-Term Debt, Current Maturities Error Corrections and Prior Period Adjustments Restatement [Line Items] Tax Credit Carryforward, Name Tax Credit Carryforward, Name [Domain] Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3 Financial assets, transfer in to level 3, amount Description of tax years open to examination by major jurisdictions Income Tax Examination, Description Commitments and Contingencies Commitments and Contingencies Disclosure [Text Block] Warrant Reclassified As Equity Warrant reclassified as equity. Reclassified as equity Schedule Of Stock By Class [Table] Stock, Class of Stock [Table] Gain Loss On Forgiveness Of Paycheck Protection Program Loan Gain on forgiveness of PPP loan Gain on forgiveness of PPP loan Gain (loss) on forgiveness of paycheck protection program loan. Product and Service Product and Service [Axis] Percentage of total shares of common stock reserved Percentage Of Increase In Common Stock Capital Shares Reserved For Future Issuance Percentage of increase in common stock capital shares reserved for future issuance. Collaborative Arrangement and Arrangement Other than Collaborative [Domain] Related Party Transaction [Line Items] Related Party Transaction [Line Items] Cybersecurity Risk Management Processes Integrated [Text Block] Increase In Dividend Percentage Points Per Year Increase in dividend percentage points per year. Increase in dividend percentage points per year Title of Individual Title and Position [Axis] November Warrant Offering. November Warrant Offering [Member] November Warrant Offering Issuance Of Preferred Ptock And Warrants Issuance of preferred stock and warrants. Issuance of preferred stock and warrants (in shares) Class of Warrant or Right [Axis] Sale of Stock Sale of Stock [Domain] Percentage of Public Warrants Issued with Holders Percentage of public warrants issued with holders. Percentage of public warrants issued with holders Class of Stock Disclosures [Abstract] Research Equipment Research Equipment [Member] Research equipment. Fair Value Measurement Inputs and Valuation Techniques [Line Items] Wages Benefits and Related Costs Wages Benefits and Related Costs [Member] Wages benefits and related costs. Entity Central Index Key Entity Central Index Key Dr. Maurice Zauderer President [Member] Collateral Held Collateral Held [Domain] Stock Options, Forfeited Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period Auditor Opinion [Text Block] Preferred Stock, Per Share Amounts of Preferred Dividends in Arrears Per-share amounts of arrearages in cumulative preferred dividends Changes in operating assets and liabilities: Increase (Decrease) in Operating Capital [Abstract] Related Party Contribution to Fund Operations in Next Fiscal Year Related party contribution to fund operations in next fiscal year. Contribution to fund operations in 2025 Common stock, shares issued Common Stock, Shares, Issued Common stock sold Fair Value Measurement Inputs and Valuation Techniques [Table] Issuance of preferred stock and warrants Issuance Of Preferred Stock And Warrants Value Issuance of preferred stock and warrants value. Measurement Input, Expected Dividend Rate [Member] Dividend Yield Prepaid expenses and other current assets Increase (Decrease) in Prepaid Expense and Other Assets Existing and New Warrants [Member] Existing and new warrants. Existing and New Warrants Preferred Stock [Member] Preferred Stock Income Statement [Abstract] 2018 Omnibus Incentive Plan Two Thousand Eighteen Employee Equity Plan [Member] Two thousand eighteen employee equity plan. Entity Address, State or Province Entity Address, State or Province Loss from operations Loss before provision for income taxes Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Total Vaccinex,Inc. Stockholders' Equity (Deficit) Parent [Member] Revision of Prior Period [Axis] Class of Warrant or Right [Table] Reserves and accruals Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Reserves Additional shares of common stock Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Additional Shares Authorized Intrinsic value of exercisable awards Aggregate Intrinsic Value, Exercisable Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value Exchange of Vaccinex Products, LP Units Exchange Of Vaccinex Products L P Units [Member] Exchange of Vaccinex Products, LP units. Treasury stock, common shares Treasury Stock, Common, Shares Balance, Shares Balance, Shares Cover [Abstract] Cover Call notice period Call notice period. Call Notice Period Net loss per share attributable to Vaccinex, Inc. common stockholders, basic Earnings Per Share, Basic Earnings Per Share, Basic, Total Increase (decrease) in valuation allowance for deferred tax asset Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount Percentage Of Share Holders Consent Required To Amend Bylaws Percentage of share holders consent required to amend bylaws. Percentage of share holders consent required to amend bylaws Number of designated milestones Number Of Designated Milestones Number of designated milestones. License And Services Agreement [Table] License And Services Agreement [Table] License and services agreement. Contract with Customer, Liability, Current Deferred revenue Document Annual Report Document Annual Report Consolidation Items [Domain] Shares Underlying Outstanding Public Warrants Shares underlying outstanding public warrants. Shares underlying outstanding public warrants [Member] Vaccinex Products VX3 Variable Interest Entity, Primary Beneficiary [Member] Total stock-based compensation expense Share-Based Payment Arrangement, Expense Deferred Tax Assets, Net [Abstract] Deferred tax assets: Change in fair value of derivative asset Unrealized Gain (Loss) on Derivatives Change in fair value of derivative asset Retained Earnings (Accumulated Deficit), Total Accumulated deficit Accumulated deficit Retained Earnings (Accumulated Deficit) Plan Name Plan Name [Axis] Segment Reporting [Abstract] Common Stock Reserved for Potential Future Issuances Common Stock Reserved For Future Issuance Table [Text Block] Common stock reserved for future issuance. Stock Options, Balance Stock Options, Balance Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number Current assets: Assets, Current [Abstract] Total shares of common stock reserved Common Stock, Capital Shares Reserved for Future Issuance Ernest S. Smith [Member] Ernest S. Smith. Ernest S. Smith UNITED STATES United States Commitments And Contingencies [Table] Commitments And Contingencies [Table] Commitments and contingencies. Net cash used in operating activities Cash flow from operations Net Cash Provided by (Used in) Operating Activities Net cash used in operating activities Product and Service Product and Service [Domain] Debt Instrument [Line Items] Debt Instrument [Line Items] Operating loss carryforwards Operating Loss Carryforwards Property and equipment, net Property and equipment, net Property, Plant and Equipment, Net CASH FLOWS FROM OPERATING ACTIVITIES: Net Cash Provided by (Used in) Operating Activities [Abstract] Type of Restructuring Type of Restructuring [Domain] Fair Value Measurements Recurring Fair Value, Recurring [Member] Convertible Debt, Total Senior secured convertible debt, net Convertible Debt Common stock, par value Common Stock, Par or Stated Value Per Share Common stock, par value Percentage of funds used to redeem outstanding debentures Percentage Of Funds Used To Redeem Outstanding Debentures Percentage of funds used to redeem outstanding debentures. Employee Stock Options Cybersecurity Risk Management Positions or Committees Responsible [Text Block] Measurement Input Type [Domain] Statement of Cash Flows [Abstract] Counterparty Name Counterparty Name [Axis] Antidilutive Securities, Name Antidilutive Securities, Name [Domain] Warrants issued Class of Warrant or Right, Number of Securities Called by Warrants or Rights Other Deferred Tax Assets, Other Balance Sheet Related Disclosures [Abstract] Equity Components Equity Components [Axis] Description of warrants right to call Description of Warrants Right To Call Description of warrants right to call. Aggregate amounts of arrearages in cumulative preferred dividends Preferred Stock, Amount of Preferred Dividends in Arrears Entity Address, Address Line One Entity Address, Address Line One Elizabeth E. Evans [Member] Elizabeth E. Evans. Elizabeth E. Evans Employee-related Liabilities, Current, Total Accrued payroll and related benefits Employee-related Liabilities, Current Schedule Of Related Party Transactions By Related Party [Table] Related Party Transaction [Table] Issuance of common stock and pre-funded warrants, net of offering costs - registered direct offering and private placement. Issuance of common stock and pre-funded warrants, net of offering costs - registered direct offering and private placement Issuance of common stock and pre-funded warrants, net of offering costs - registered direct offering and private placement Cybersecurity Risk Process for Informing Board Committee or Subcommittee Responsible for Oversight [Text Block] Computer Equipment Computer Equipment [Member] Valuation Approach and Technique Valuation Approach and Technique [Axis] Property Plant And Equipment [Line Items] Property, Plant and Equipment [Line Items] Exercise price as a percentage of fair value of common stock on grant date if optionee owns stock representing more than 10 percent of voting power of all classes of stock Exercise Price As Percentage Of Fair Value Of Common Stock On Grant Date If Optionee Owns Stock Representing More Than10 Percent Of Voting Power Of All Classes Of Stock Exercise price as percentage of fair value of common stock on grant date if optionee owns stock representing more than 10 percent of voting power of all classes of stock. Accrued and Make-whole Interest Accrued And Make Whole Interest [Member] Accrued and make-whole interest. Subsequent Event Type [Axis] Subsequent Event Weighted-Average Common Stock Equivalents Excluded from Calculation of Diluted Net Loss Per Share as They Had Anti-Dilutive Effect Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block] Percentage of voting interest Variable Interest Entity, Qualitative or Quantitative Information, Ownership Percentage Risk-free interest rate Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate Annual maintenance fee Cost, Maintenance Research and development credit, net Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent Research and development credit, net Entity Voluntary Filers Entity Voluntary Filers Amendment Flag Amendment Flag ASC 842 Accounting Standards Update 2016-02 [Member] Operating Loss Carryforwards [Table] Operating Loss Carryforwards [Table] Tax credit carryforwards, expiration date Tax Credit Carryforward, Expiration Date Operating lease liability, net of current portion Operating Lease, Liability, Noncurrent Proceeds from the sale of shares Sale of Stock, Consideration Received Per Transaction Federal Domestic Tax Jurisdiction [Member] Additional paid-in capital Additional Paid in Capital, Common Stock Embedded derivative liability Embedded Derivative, Fair Value of Embedded Derivative Liability Shares Underlying Outstanding Pre-funded Warrants Shares underlying outstanding pre-funded warrants. Shares underlying outstanding pre-funded warrants [Member] Extinguishment of Debt, Type Extinguishment of Debt, Type [Domain] Shares Underlying Outstanding Stock Options Shares Underlying Outstanding Stock Options [Member] Shares underlying outstanding stock options. Shares issued, price per share Sale of Stock, Price Per Share Preferred Stock, Voting Rights Preferred stock, voting rights Warrants. Warrants [Policy Text Block] Warrants Net loss attributable to Vaccinex, Inc. common stockholders Lessee Lease Description [Table] Lessee, Lease, Description [Table] Stock Options, Exercisable Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number Research and Development Research and Development Expense [Member] Equity Component Equity Component [Domain] Percentage of voting power of all classes of stock to be owned by optionee to determine the exercise price Percentage Of Voting Power Of All Classes Of Stock To Be Owned By Optionee To Determine Exercise Price Percentage of voting power of all classes of stock to be owned by optionee to determine exercise price. Jacob Frieberg Director Three Member Director. Statistical Measurement Statistical Measurement [Domain] Document Financial Statement Error Correction [Flag] Existing warrants [Member] Existing warrants. Existing Warrants General and Administrative Expense, Total General and administrative General and Administrative Expense Short Term Debt [Line Items] Short-Term Debt [Line Items] Balance Sheet Components Supplemental Balance Sheet Disclosures [Text Block] Interest Expense, Debt, Total Interest expense Debt related charges included in interest expense Interest Expense, Debt Other Nonoperating Income (Expense), Total Other income (expense), net Other Nonoperating Income (Expense) Stock options granted, expiration year Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Text Block] Furniture and Fixtures Furniture and Fixtures [Member] Treasury Stock, Common [Member] Treasury Stock Cybersecurity Risk Management Processes Integrated [Flag] Schedule of changes in derivative assets [Table Text Block] Schedule of changes in derivative assets [Table Text Block] Schedule of Changes in Derivative Assets Net loss Net loss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest Convertible preferred stock (Series A), issued Preferred Stock, Shares Issued Cash paid for amount included in measurement of lease liabilities Operating Lease, Payments Lessee operating lease, incremental borrowing rate Lessee, Operating Lease, Discount Rate Payables and Accruals [Abstract] VX3 License Agreement V X Three License Agreement [Member] V X Three license agreement. CARES Act of 2020 aid forgiveness amount C A R E S Act Of2020 Aid Forgiveness Amount CARES Act of 2020 aid forgiveness amount. Issuance of common stock and pre-funded warrants value. Issuance Of Common Stock And Pre-funded Warrants Value Issuance of common stock, pre-funded warrants, and private placement warrants Consolidation Items [Axis] Operating Lease, Expense Rent expense incurred under operating lease Original issuance discount Original Issuance Discount Of Convertible Debentures Original issuance discount of convertible debentures. Prepaid expenses and other current assets Prepaid Expense and Other Assets, Current Weighted-Average Exercise Price, Forfeited Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price Service fee payment received Upfront payments fee received Proceeds from Collaborators Preferred Stock, Liquidation Preference, Value Liquidation value Convertible preferred stock (Series A), aggregate liquidation preference Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Class of Stock Class of Stock [Domain] Measurement Input, Share Price [Member] Share Price Change In Fair Value of Derivative Asset Change in fair value derivative asset. Change in fair value Collaboration Agreements Collaborative Arrangement Disclosure [Text Block] Comprehensive loss Comprehensive loss Comprehensive Income (Loss), Net of Tax, Attributable to Parent Common Stock, Shares, Outstanding, Ending Balance Common Stock, Shares, Outstanding, Beginning Balance Common stock, shares outstanding Common Stock, Shares, Outstanding Maximum contractual life for options granted Share Based Compensation Arrangement By Share Based Payment Award Options Maximum Contractual Term Share-based compensation arrangement by share-based payment award, options, maximum contractual term. Convertible preferred stock (Series A), par value Preferred Stock, Par or Stated Value Per Share Research and development tax credits Deferred Tax Asset, In-Process Research and Development Common warrants two. Common Warrants Two [Member] Common Warrants Antidilutive Securities Antidilutive Securities [Axis] Convertible Preferred Stock [Text Block] Convertible Preferred Stock Convertible Preferred Stock Cybersecurity Risk Process for Informing Management or Committees Responsible [Text Block] Proceeds from Issuance or Sale of Equity, Total Proceeds from Issuance or Sale of Equity Aggregate purchase price Entity Interactive Data Current Entity Interactive Data Current Interest related to income taxes Income Tax Examination, Interest Accrued Early termination or prepayment penalties Payment for Debt Extinguishment or Debt Prepayment Cost Debenture redemption percentage Debt Instrument, Redemption Price, Percentage Accounting Standards Update Accounting Standards Update [Domain] Adjustments to additional paid in capital, reclassification of public warrants as amended Adjustments to additional paid in capital, reclassification of public warrants as amended. Reclassification of public warrants, as amended Consolidated Entities Consolidated Entities [Axis] Proceeds from capital contribution Proceeds from capital contribution Proceeds from Contributed Capital Related Party Transactions Related Party Transactions Disclosure [Text Block] Statistical Measurement Statistical Measurement [Axis] Research Research Tax Credit Carryforward [Member] Total Financial Assets Assets, Fair Value Disclosure Senior Secured Convertible Debenture Convertible Debt [Member] Related Party Related and Nonrelated Parties [Domain] Board of Directors Director [Member] Accrued interest Interest Payable Total unrecognized compensation cost related to stock options granted to employees, weighted-average recognition period Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition Proceeds from private offering of common stock Proceeds from Issuance of Private Placement Net deferred tax assets and liability Deferred Tax Assets, Net Research and Development Costs Research and Development Expense, Policy [Policy Text Block] Pre-funded Warrants and Public Warrants Pre funded warrants and public warrants. Pre Funded Warrants And Public Warrants [Member] Income Statement Location Statement of Income Location, Balance [Axis] Schedule Of Short Term Debt [Table] Short-Term Debt [Table] TOTAL ASSETS Assets Expected term (in years) Expected term of stock option Expected term (years) Restructuring Type Restructuring Type [Axis] Securities purchase agreement. Securities Purchase Agreement [Member] Securities Purchase Agreement Debt Instrument [Table] Schedule of Long-Term Debt Instruments [Table] A D D F Warrant [Member] ADDF Warrant. ADDF Warrant Summary of Estimated Useful Lives for Property and Equipment Estimated Useful Lives For Property And Equipment Table [Text Block] Estimated useful lives for property and equipment. Extinguishment of Debt Extinguishment of Debt [Axis] New Accounting Pronouncements, Policy [Policy Text Block] Recently Issued Accounting Pronouncements Entity Address, City or Town Entity Address, City or Town Revision of Prior Period, Adjustment [Member] Adjustments Equity [Abstract] Auditor Location Auditor Location Financial Assets: Assets, Fair Value Disclosure [Abstract] Operating Leases, Future Minimum Payments Due Future minimum operating leases payment in total Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Flag] Consulting Non Clinical Trial Services and Other [Member] Consulting non clinical trial services and other. Consulting Non-Clinical Trial Services and Other License And Services Agreement [Line Items] License And Services Agreement [Line Items] License and services agreement. Debt instrument principal amount Debt Instrument, Face Amount FCMI Parent Co. and Friedberg Global-Macro Hedge Fund Ltd. Investor [Member] Depreciation, Total Depreciation Depreciation Revision of Prior Period [Domain] Financing Activities Deferred Charges, Policy [Policy Text Block] Schedule of Segment Reporting Information, by Segment [Table] Financial assets, level 2 to level 1 transfer, amount Fair Value Assets Level 2 To Level 1 Transfer Amount Amount of transfer of assets measured on a recurring basis out of Level 2 of the fair value hierarchy into Level 1. Sale of stock, transaction date Sale of Stock, Transaction Date Cybersecurity Risk Third Party Oversight and Identification Processes [Flag] Private Placement [Member] Private Placement Offerings Private Placement Stock-Based Compensation Share-Based Payment Arrangement [Text Block] Cybersecurity Risk Management Positions or Committees Responsible Report to Board [Flag] Series A Preferred Stock [Member] Series A Preferred Stock Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Expirations in Period Stock Options, Expired Stock Options, Expired Segment Reporting, CODM, Individual Title and Position or Group Name [Extensible Enumeration] Fair Value Disclosures [Abstract] Pre-funded warrants. Pre-funded Warrants [Member] Pre-funded Warrants Entity Public Float Entity Public Float Issuance of Common Shares Stock Issued During Period, Value, New Issues Aggregate offering price Net deferred tax assets Deferred Tax Assets, Net of Valuation Allowance Chief Executive Officer Chief Executive Officer [Member] Lessee Lease Description [Line Items] Lessee, Lease, Description [Line Items] Current liabilities: Liabilities, Current [Abstract] Leases Leases Disclosure [Text Block] Leases disclosure. Document Type Document Type Document Type Accounting Standards Update Accounting Standards Update [Axis] Warrants exercised Warrants exercised. Asset Impairment Charges, Total Asset impairment charges Asset Impairment Charges Title of 12(b) Security Title of 12(b) Security Cash and Cash Equivalents, at Carrying Value, Total Cash and cash equivalents Cash and Cash Equivalents, at Carrying Value Weighted-Average Remaining Contractual Life (Years), Granted Sharebased Compensation Arrangement By Sharebased Payment Award Options Granted Weighted Average Remaining Contractual Term1 Sharebased Compensation Arrangement By Sharebased Payment Award Options Granted Weighted Average Remaining Contractual Term1 Exercise of warrants (in shares) Stock issued during period shares exercise of warrants Stock issued during period shares exercise of warrants. Cybersecurity Risk Management, Strategy, and Governance [Line Items] Statement of Stockholders' Equity [Abstract] If Converted Common Shares From Convertible Preferred Stock [Member] If converted common shares from convertible preferred stock. If Converted Common Shares From Convertible Preferred Stock Document Fiscal Period Focus Document Fiscal Period Focus Shares underlying convertible preferred stock-if converted [Member] Shares underlying convertible preferred stock-if converted. Shares Underlying Convertible Preferred Stock-if Converted January 2022 Private Placement January Two Thousand Twenty Two Private Placement [Member] January 2022 Private Placement. Aggregate Intrinsic Value, Exercised Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period, Intrinsic Value Research and Development Expense, Total Research and development Research and Development Expense Total research and development expenses Long-Term Debt, Excluding Current Maturities, Total Long-term debt Long-Term Debt, Excluding Current Maturities Percentage of Cancelled Warrants in Outstanding Shares Percentage of cancelled warrants in outstanding shares. Percentage of cancelled warrants in outstanding shares Options granted Stock Options, Granted Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross Preferred Stock, Dividend Rate, Percentage Preferred stock, dividend rate Property, Plant and Equipment, Gross, Ending Balance Property, Plant and Equipment, Gross, Beginning Balance Property, Plant and Equipment, Gross, Total Property and equipment, gross Property, Plant and Equipment, Gross Subsequent Event Type [Domain] Subsequent Event Measurement Input, Expected Term [Member] Expected Term (Years) Expected Term (in years) Grant Date Fair Value of Employee Stock Options Estimated Using Black-Scholes Option-Pricing Model with Weighted-Average Assumptions Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] Depreciation and amortization Deferred Tax Assets Depreciation And Amortization Deferred tax assets depreciation and amortization Operating Segments Operating Segments [Member] Error Correction [Table] November 2022 Private Placement November Two Thousand Twenty Two Private Placement [Member] November two thousand twenty two private placement. Accounting Changes and Error Corrections [Abstract] Exercise price of warrants Class of Warrant or Right, Exercise Price of Warrants or Rights Financial Instruments Financial Instruments [Domain] Minimum Limit Of Borrowings Minimum limit of borrowings. Minimum limit of borrowings Class of Warrant or Right [Line Items] Sale of Stock Sale of Stock [Axis] CASH FLOWS FROM INVESTING ACTIVITIES: Net Cash Provided by (Used in) Investing Activities [Abstract] Expected Volatility Measurement Input Expected Volatility [Member] Measurement input expected volatility. Revenue from Contract with Customer, Excluding Assessed Tax, Total Revenue Revenue from Contract with Customer, Excluding Assessed Tax Income Taxes Income Tax Disclosure [Text Block] Amortization of preferred stock discount Amortization of Preferred Stock Discount Value Amortization of preferred stock discount vlaue. Schedule of Effective Income Tax Rate Reconciliation Schedule of Effective Income Tax Rate Reconciliation [Table Text Block] Cybersecurity Risk Management, Strategy, and Governance [Abstract] Consolidated Entities Consolidated Entities [Domain] Warrants and Rights Note Disclosure [Abstract] September two thousand twenty three private placement. September Two Thousand Twenty Three Private Placement [Member] September 2023 Private Placement Short-term Debt, Type Short-Term Debt, Type [Axis] Short-term Debt, Type Short-Term Debt, Type [Domain] Investor three. Investor Three [Member] Vaccinex (Rochester) L.L.C. Accrued other Other Accrued Liabilities, Current Increase (Decrease) in Accounts Payable, Total Accounts payable Increase (Decrease) in Accounts Payable Deferred tax liability: Deferred Tax Liabilities, Net [Abstract] VX3 Interests V X3 Interests [Member] VX3 interests. Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology [Abstract] LIABILITIES AND STOCKHOLDERS’ EQUITY Liabilities and Equity [Abstract] Document Period End Date Document Period End Date Net cash provided by financing activities Net Cash Provided by (Used in) Financing Activities Net cash provided by financing activities Non-deductible items and others Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent Preferred Stock and Warrants [Member] Preferred stock and warrants. Preferred Stock and Warrants ICFR Auditor Attestation Flag ICFR Auditor Attestation Flag Total Effective Income Tax Rate Reconciliation, Percent Weighted-average common stock equivalents excluded from calculation of diluted net loss per share Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount APIC, Share-Based Payment Arrangement, Increase for Cost Recognition, Total Stock-based compensation APIC, Share-Based Payment Arrangement, Increase for Cost Recognition Sale of stock, consideration received Sale of Stock, Consideration Received on Transaction Accrued expenses Accrued expenses Accrued Liabilities, Current Warrant liability Derivative Liability, Current Segment Reporting, CODM, Profit (Loss) Measure, How Used, Description Public warrants. Public Warrants [Member] Public Warrants Public Warrants to Purchase Common Stock Income Tax Expense (Benefit), Total Provision for income taxes Income Tax Expense (Benefit) Issuance of convertible preferred stock Convertible preferred stock issued Convertible preferred stock issued. Trading Symbol Trading Symbol Document Financial Statement Restatement Recovery Analysis [Flag] Derivative Asset, Measurement Input Derivative asset measurement input Gain (loss) on warrant issuance Gain (loss) on warrant issuance. Loss on warrant issuance Total deferred tax assets Deferred Tax Assets, Gross Debt Instrument, Periodic Payment, Total Monthly repayment Debt Instrument, Periodic Payment Long-Lived Tangible Asset Long-Lived Tangible Asset [Axis] Class of Warrant or Right, Outstanding Warrants outstanding Stock-Based Compensation Share-Based Payment Arrangement [Policy Text Block] Aggregate number of shares issued and sold Sale of Stock, Number of Shares Issued in Transaction Number of shares sold Aggregate number of shares issued and sold Related Party Transactions [Abstract] Common Warrants Common warrants. Common Warrants [Member] 2011 Employee Equity Plan Two Thousand Eleven Employee Equity Plan [Member] Two thousand eleven employee equity plan. Deferred revenue Increase (Decrease) in Deferred Revenue Gain (loss) on settlement of warrants Gain (loss) on settlement of warrants. Loss on settlement of warrants Loss on settlement of warrants Schedule Of Property Plant And Equipment [Table] Property, Plant and Equipment [Table] Cybersecurity Risk Management, Strategy, and Governance [Table] Maurice Zauderer. Maurice Zauderer [Member] Maurice Zauderer Cybersecurity Risk Management Expertise of Management Responsible [Text Block] Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block] Total Stock-Based Compensation Expense Recognized in Consolidated Statements of Operations and Comprehensive Loss Measurement Input Type [Axis] Statistical significance value of pepinemab or placebo. Statistical Significance Value Of Pepinemab Or Placebo Statistical significance of p-value Geographical [Axis] Total unrecognized compensation cost related to stock options granted to employees Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount Leases [Abstract] Derivative asset Derivative Asset, Current Issuance of warrants Warrants issued. Warrants Issued Use of Estimates Use of Estimates, Policy [Policy Text Block] Friedberg Global-Macro Hedge Fund Ltd. Investor Two Member Investor. Maximum employee contribution to plan Defined Contribution Plan, Maximum Annual Contributions Per Employee, Percent Shares Available For Future Stock Option Grants Shares Available For Future Stock Option Grants [Member] Shares available for future stock option grants. Cash and Cash Equivalents Cash and Cash Equivalents, Policy [Policy Text Block] Class Of Stock [Line Items] Class of Stock [Line Items] Scenario Scenario [Axis] Expected dividend yield Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate Dividend yield Security Exchange Name Security Exchange Name 3i Collateral Agent And Purchaser [Member] Collateral agent and purchaser. Debt instrument, discount rate Debt Instrument Discount Rate Debt instrument, discount rate. Counterparty Name Counterparty Name [Domain] Operating Loss Carryforwards [Line Items] Operating Loss Carryforwards [Line Items] Common stock reverse split. Common Stock Reverse Split [Policy Text Block] Common Stock Reverse Split Measurement Input, Risk Free Interest Rate [Member] Risk-Free Interest Rate Summary Of Significant Accounting Policies [Table] Summary Of Significant Accounting Policies [Table] Tabular disclosure of summary of significant accounting policies. Long-Lived Tangible Asset Long-Lived Tangible Asset [Domain] Description of public warrants right to call. Description Of Public Warrants Right To Call Description of public warrants right to call Class of Stock Class of Stock [Axis] Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Ending Balance Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Beginning Balance Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Total Less: accumulated depreciation and amortization Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Fair Value of Financial Measurements Fair Value Disclosures [Text Block] Weighted-average grant date fair value of stock options granted to employees and directors Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value Error Correction [Text Block] Restatement Subsequent Event [Member] Subsequent Events Maximum Maximum [Member] TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY Liabilities and Equity Operating lease right-of-use asset Operating lease right-of-use asset Operating Lease, Right-of-Use Asset February 2024 Private Placement February two thousand twenty four private placement. February Two Thousand Twenty Four Private Placement [Member] Retirement Benefits [Abstract] Net loss per share attributable to Vaccinex, Inc. common stockholders, diluted Earnings Per Share, Diluted Earnings Per Share, Diluted, Total Leasehold Improvements Leasehold Improvements [Member] Entity Ex Transition Period Entity Ex Transition Period TOTAL LIABILITIES Liabilities Research and Development [Abstract] Fair Value Hierarchy and NAV Fair Value Hierarchy and NAV [Domain] Total current assets Assets, Current Net cash used in investing activities Net Cash Provided by (Used in) Investing Activities Scenario Forecast Forecast [Member] Issuance of Common Shares, Shares Stock Issued During Period, Shares, New Issues Public Offering and Private Placement Public Offering and Private Placement. Public Offering and Private Placement [Member] Change in valuation allowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent Change in valuation allowance Vesting period of stock option grants Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period Penalties related to income taxes Income Tax Examination, Penalties Accrued Entity Filer Category Entity Filer Category Lessee, operating lease, discount rate, description Lessee, Operating Lease, Assumptions and Judgments, Discount Rate, Description Property, Plant and Equipment [Abstract] Preclinical Supplies and Equipment Depreciation [Member] Preclinical supplies and equipment depreciation. Preclinical Supplies and Equipment Depreciation Balance Balance Equity, Including Portion Attributable to Noncontrolling Interest Stockholders' deficit TOTAL STOCKHOLDERS' EQUITY/(DEFICIT) Company and Nature of Business Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block] Unrecognized tax benefits that would impact effective tax rate Unrecognized Tax Benefits that Would Impact Effective Tax Rate Current Fiscal Year End Date Current Fiscal Year End Date Stockholders’ equity (deficit): Equity, Including Portion Attributable to Noncontrolling Interest [Abstract] Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Property and Equipment, Net Property, Plant and Equipment, Policy [Policy Text Block] Aggregate grant date fair value of stock options vested Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested in Period, Fair Value Noncontrolling Interests Noncontrolling Interest [Member] Imputed interest Lessee, Operating Lease, Liability, Undiscounted Excess Amount Summary of Changes in Fair Value of Company's Warrant Liabilities that is Recognized in Change in Fair Value of Warrant Liabilities in Accompanying Statements of Operations and Comprehensive Loss Summary of changes in fair value of warrant liabilities table text block. Summary of Changes in Fair Value of Warrant Liabilities [Table Text Block] Share-Based Payment Arrangement, Noncash Expense, Total Stock-based compensation Share-Based Payment Arrangement, Noncash Expense Intrinsic value of outstanding awards Aggregate Intrinsic Value, Balance Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value Related Party Related and Nonrelated Parties [Axis] Maximum beneficial ownership limitation Maximum beneficial ownership limitation. Maximum Beneficial Ownership Limitation Entity Registrant Name Entity Registrant Name May 2023 Private Placement May Two Thousand Twenty Three Private Placement [Member] May two thousand twenty three private placement. Issuance of Preferred Stock and Warrants, Shares Issuance of preferred stock and warrants, shares. Issuance of preferred stock and warrants (in shares) Employee Benefit Plan Compensation and Employee Benefit Plans [Text Block] Gerald Van Strydonck Director Member One Member Director. Number of Reportable Segments Number of reportable segments Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table] Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Net Loss Per Share Attributable to Common Stockholders Earnings Per Share [Text Block] Maturity date Debenture maturity date Debt Instrument, Maturity Date Entity Emerging Growth Company Entity Emerging Growth Company Summary Of Significant Accounting Policies [Line Items] Summary Of Significant Accounting Policies [Line Items] Line items represent represents lime items of summary of significant accounting policies.. Proceeds from issuance of common stock, and pre-funded warrants Proceeds from Issuance of Common Stock, and Pre-Funded Warrants Proceeds from issuance of common stock, and pre-funded warrants. Money Market Funds Money Market Funds [Member] Weighted-average shares used in computing net loss per share attributable to Vaccinex, Inc. common stockholders, basic Weighted Average Number of Shares Outstanding, Basic Weighted Average Number of Shares Outstanding, Basic, Total October 2023 Offering. October 2023 Offering [Member] October 2023 Offering Exclusive Product License Exclusive Product License [Member] Exclusive product license. Repayments of convertible debt Repayments of Convertible Debt Common stock, shares authorized Common Stock, Shares Authorized Warrant liabilities. Warrant Liabilities Warrant liabilities Warrant liabilities, beginning balance Warrant liabilities, ending balance Notice period to change beneficial ownership limitation Notice period to change beneficial ownership limitation. Notice Period To Change Beneficial Ownership Limitation Property, Plant and Equipment, Useful Life Property, Plant and Equipment, Useful Life Gross proceeds from issuance of common stock Proceeds from issuance of common stock Proceeds Level 1 Fair Value, Inputs, Level 1 [Member] Debt Disclosure [Abstract] PPP Loan Paycheck Protection Program [Member] Paycheck protection program. Long-Term Debt [Text Block] Debt Weighted-Average Exercise Price, Granted Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Financial Instrument Financial Instrument [Axis] Weighted-Average Remaining Contractual Life (Years), Balance Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term Net Loss Per Share Attributable to Vaccinex, Inc. Common Stockholders Earnings Per Share, Policy [Policy Text Block] Amount of loan received C A R E S Act Of2020 Aid Amount CARES act of 2020 aid amount. General and Administrative General and Administrative Expense [Member] Number of target antigens against which antibodies are to be identified and selected Number Of Target Antigens Against Which Antibodies Are To Be Identified And Selected Number of target antigens against which antibodies are to be identified and selected. Share-Based Payment Arrangement [Abstract] Impairment of Long-Lived Assets Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block] Issuance of common stock and pre-funded warrants, net of offering costs - registered direct offering and private placement, shares. Issuance of common stock and pre-funded warrants, net of offering costs - registered direct offering and private placement, shares Issuance of common stock and pre-funded warrants, net of offering costs - registered direct offering and private placement, Shares Schedule Of Collaborative Arrangements And Noncollaborative Arrangement Transactions [Table] Collaborative Arrangement and Arrangement Other than Collaborative [Table] Proceeds from Issuance of Warrants Proceeds from issuance of warrants Measurement input volatility member. Measurement Input Volatility [Member] Volatility Cybersecurity Risk Role of Management [Text Block] Balance Treasury Stock, Common, Value Balance Treasury Stock Treasury Stock Policy [Text Block] Treasury stock. Maximum common stock purchased Maximum Common Stock Purchased Maximum common stock purchased. Accounting Policies [Abstract] Summary of Stock Option Activity and Related Information Share-Based Payment Arrangement, Option, Activity [Table Text Block] Long-Term Line of Credit Long-Term Line of Credit, Total Balance outstanding Income Tax Disclosure [Abstract] Research and development, milestone payments to company Research And Development Milestone Payments Research and development milestone payments. Measurement Input, Exercise Price [Member] Exercise Price (per share) Statement [Table] Statement [Table] Segment and Geographic Information Segment Reporting, Policy [Policy Text Block] Property and Equipment Property, Plant and Equipment [Table Text Block] Basis of Presentation and Consolidation Basis Of Presentation And Consolidation Policy [Text Block] Basis of presentation and consolidation. Debt Instruments [Abstract] Warrants Reclassified As Equity [Member] Warrants reclassified as equity. Warrants Reclassified As Equity Convertible preferred stock (Series A), authorized Preferred Stock, Shares Authorized FCMI Parent Co. Investor One Member Investor. Change in fair value of warrant liabilities Change in fair value of warrant liability Change in fair value Change in fair value Change in fair value of warrant liabilities Entity File Number Entity File Number Segment Information Segment Reporting Disclosure [Text Block] NET DECREASE IN CASH AND CASH EQUIVALENTS Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Earnings Per Share [Abstract] Warrants and Rights Outstanding, Term Warrants expiration period State taxes, net of federal benefit Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent Statement of Financial Position [Abstract] Tax Credit Carryforward Tax Credit Carryforward [Axis] Interest Expense, Total Interest expense Interest Expense, Operating and Nonoperating Interest expense IPO [Member] Public Offering Collaboration Agreements [Abstract] Collaboration agreements. Loss from operations Operating Income (Loss) Expected volatility Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate Derivative Asset Derivative Asset, Total Derivative asset Derivative asset as of December 31, 2024 Derivative asset as of January 1, 2024 Entity Shell Company Entity Shell Company Accrued consulting and legal Accrued Professional Fees, Current Fair Value Measurement Inputs and Valuation Techniques [Table Text Block] Summary of Key Inputs into Valuation Models Used to Estimate Fair Value of Warrant Liabilities Annual effective interest rate Debt Instrument, Interest Rate, Effective Percentage Entity Tax Identification Number Entity Tax Identification Number ASSETS Assets [Abstract] Schedule of Error Corrections and Prior Period Adjustments [Table Text Block] Summary of Effects of Restatement by Financial-Statement Line Item Affected Class of Warrant or Right [Domain] Fair Value of Financial Instruments Fair Value of Financial Instruments, Policy [Policy Text Block] Entity Current Reporting Status Entity Current Reporting Status Weighted-Average Remaining Contractual Life (Years), Exercisable Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term Gross proceeds from exercise and sale of warrants Gross proceeds from exercise and sale of warrants. License and Services Agreement License And Services Agreement [Text Block] License and services agreement. Proceeds from issuance of convertible preferred stock Proceeds from Issuance of Convertible Preferred Stock Long-term Debt, Type Long-Term Debt, Type [Axis] Subsequent Events [Abstract] Revenue Recognition Revenue from Contract with Customer [Policy Text Block] Base amount to determine issuance of common stock upon termination Base Amount To Determine Issuance Of Common Stock Upon Termination Base amount to determine issuance of common stock upon termination. Previously Reported [Member] Previously Reported Geographical [Domain] Document Fiscal Year Focus Document Fiscal Year Focus Preferred Stock, Value, Issued Convertible preferred stock (Series A), par value of $0.001 per share; 10,000,000 shares authorized, 10 shares issued and outstanding as of December 31, 2024, and no shares authorized, issued or outstanding as of December 31, 2023; with aggregate liquidation preference of $1,750,000 and $0 as of December 31, 2024 and December 31, 2023, respectively Clinical Trial Costs [Member] Clinical trial costs. Clinical Trial Costs Repayments of Long-Term Debt, Total Payments of long-term debt Repayments of Long-Term Debt Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations, Total CASH AND CASH EQUIVALENTS–Beginning of period CASH AND CASH EQUIVALENTS–End of period Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations Schedule of Quantitative Information Regarding Measurement Inputs to Estimate the Fair Value of Asset [Table Text Block] Schedule of quantitative information regarding measurement inputs to estimate the fair value of asset. Schedule of Quantitative Information Regarding Measurement Inputs to Estimate the Fair Value of Asset Tax credit carryforwards Tax Credit Carryforward, Amount City Area Code City Area Code Warrants and Rights Outstanding, Measurement Input Warrant liabilities measurement input Total current liabilities Liabilities, Current Open Market Sale Agreement Open Market Sale Agreement [Member] Open market sale agreement. Purchase price of convertible debentures Purchase Price Of Convertible Debentures Purchase price of convertible debentures. Common and Pre-Funded Warrants Common and pre-funded warrants. Common And Pre Funded Warrants [Member] Expected income tax benefit at the federal statutory rate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent Financial assets, level 1 to level 2 transfer, amount Fair Value Assets Level 1 To Level 2 Transfer Amount Amount of transfer of assets measured on a recurring basis out of Level 1 of the fair value hierarchy into Level 2. Organization, Consolidation and Presentation of Financial Statements [Abstract] Local Phone Number Local Phone Number Preferred Stock, Shares Outstanding Preferred Stock, Shares Outstanding, Ending Balance Preferred Stock, Shares Outstanding, Beginning Balance Convertible preferred stock (Series A), outstanding Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Fair Value Measurement Inputs and Valuation Techniques [Abstract] Income Tax Authority Income Tax Jurisdiction [Axis] Proceeds from exercise of warrants Proceeds from Warrant Exercises Pre funding of common stock shares Pre-funding of common stock shares. Pre-funding of common stock shares Income Taxes Income Tax, Policy [Policy Text Block] Commitments and Contingencies Disclosure [Abstract] Treasury Stock, Value, Total Treasury Stock, Value Treasury stock, at cost; 5 shares of common stock as of December 31, 2024, and December 31, 2023, respectively Schedule of Deferred Tax Assets and Liabilities Schedule of Deferred Tax Assets and Liabilities [Table Text Block] Operating lease liability Operating Lease, Liability, Current Financial assets, transfer out of level 3, amount Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers out of Level 3 Income Tax Authority Income Tax Jurisdiction [Domain] Annual interest rate Debt instrument interest rate Debt Instrument, Interest Rate, Stated Percentage Accumulated Deficit Retained Earnings [Member] Amortization expense of the original issue discount Amortization of Debt Issuance Costs and Discounts Amortization of Debt Issuance Costs and Discounts, Total Payments to Acquire Property, Plant, and Equipment, Total Purchase of property and equipment Payments to Acquire Property, Plant, and Equipment Albert D. Friedberg Board of Directors Board of Directors Chairman [Member] Proceeds from Issuance of Preferred Stock, Preference Stock, and Warrants Proceeds from Issuance of Preferred Stock, Preference Stock, and Warrants, Total Proceeds from issuance of preferred stock and warrants Summary of Fair Value of Financial Assets by Level within Fair Value Hierarchy Fair Value Measurements, Recurring and Nonrecurring [Table Text Block] Document Transition Report Document Transition Report Payments commencement date Debt Instrument, Date of First Required Payment Operating loss carryforwards, expiration date Operating Loss Carryforwards, Expiration Date Valuation Approach and Technique Valuation Approach and Technique [Domain] Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Table] Antidilutive Security, Excluded EPS Calculation [Table] Number of trading days Number of trading days. Number Of Trading Days Concentration of Credit Risk, Other Risks and Uncertainties Concentration Risk, Credit Risk, Policy [Policy Text Block] Auditor Firm ID Auditor Firm ID Minimum Minimum [Member] Minimum [Member] Common Stock Common Stock [Member] Proceeds from issuance of liability classified warrants in private placement offerings Proceeds from issuance of liability classified warrants in private placement offerings. Proceeds from issuance of liability classified warrants in private placement offerings March 2023 Private Placement March Two Thousand Twenty Three Private Placement [Member] March two thousand twenty three private placement. Common stock and warrants. Common Stock And Warrants [Member] Common Stock and Warrants Commitments And Contingencies [Line Items] Commitments And Contingencies [Line Items] Commitments and contingencies. Additional Paid-in Capital Additional Paid-in Capital [Member] Inducement Letter Agreements Inducement letter agreements [Member] Inducement letter agreements. Entity Seasoned Well Known Issuer Entity Well-known Seasoned Issuer Grant revenue Grant Revenue Grant revenue. Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Adjustments to reconcile net loss to net cash used in operating activities: Private placement warrants. Private Placement Warrants [Member] Private Placement Warrants Private Placement Warrants to Purchase Common Stock Income Statement Location Statement of Income Location, Balance [Domain] New Warrants New Warrants [Member] New warrants. Deferred Tax Assets, Research and development expenses Deferred Tax Assets, Research and development expenses Research and development expenses Contract Termination Contract Termination [Member] Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Property, Plant, and Equipment, Useful Life, Term, Description [Extensible Enumeration] Common Stock Reserved For Issuance Common Stock Reserved For Issuance [Text Block] Common stock reserved for issuance. Maximum Limit Dividend Rate Can Increase Maximum limit dividend rate can increase . Maximum limit dividend rate can increase Basis of Accounting, Policy [Policy Text Block] Basis of Presentation Financing costs - warrant liabilities. Financing costs - warrant liabilities Financing costs - warrant liabilities Scenario Scenario [Domain] Title of Individual Title and Position [Domain] Common Stock, Value, Issued Common stock, par value of $0.0001 per share; 100,000,000 shares authorized as of December 31,2024 and December 31,2023; 2,676,642 and 892,622 shares issued as of December 31,2024 and December 31,2023 respectively; 2,676,637 and 892,617 shares outstanding as of December 31,2024 and December 31,2023, respectively Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items] Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] Cash and Cash Equivalents, Fair Value Disclosure Cash equivalents Surface Oncology, Inc. Surface Oncology Inc [Member] Surface Oncology, Inc. Issuance of common stock and pre-funded warrants shares. Issuance Of Common Stock And Pre-funded Warrants Shares Issuance of common stock, pre-funded warrants, and private placement warrants Exercise of warrants Stock issued during period value exercise of warrants Stock issued during period value exercise of warrants. Cancellation of warrants Warrants cancelled Warrants cancelled. Adjustments to additional paid in capital, reclassification of warrants Adjustments to additional paid in capital, reclassification of warrants. Reclassification of public and private placement warrants, as amended Operating lease liability Operating Lease, Liability, Total Operating lease liability Operating Lease, Liability Measurement Frequency Measurement Frequency [Axis] Accrued Expenses Schedule of Accrued Liabilities [Table Text Block] Deferred Tax Assets, Operating Loss Carryforwards, Total Federal and state net operating loss carryforwards Deferred Tax Assets, Operating Loss Carryforwards Commitments and Contingencies Commitments and contingencies (Note 6) Weighted Average Number of Shares Outstanding, Diluted Weighted-average shares used in computing net loss per share attributable toVaccinex, Inc. common stockholders, diluted Weighted Average Number of Shares Outstanding, Diluted, Total Summary of Significant Accounting Policies Significant Accounting Policies [Text Block] Schedule of Segment Reporting Information, by Segment [Table Text Block] Summary of Disaggregated Research and Development Expenses Accounts Receivable, after Allowance for Credit Loss, Current, Total Accounts receivable Accounts Receivable, after Allowance for Credit Loss, Current Alzheimers Association Alzheimers Association [Member] Alzheimer’s association. Limited partnership interests exchanged Partners' Capital Account, Units, Converted Cybersecurity Risk Management Third Party Engaged [Flag] Proceeds from issuance of common stock, pre-funded warrants, and private placement warrants Proceeds from issuance of common stock, pre-funded warrants, and private placement warrants Proceeds from issuance of common stock, pre-funded warrants, and private placement warrants Measurement Input, number of shares [Member] Measurement input, number of shares. Number of shares Warrants and Rights Outstanding, Maturity Date Warrant expiration date Terms of license agreement upon termination Terms Of License Agreement Upon Termination Terms of license agreement upon termination. Shares underlying outstanding private placement warrants. Shares underlying outstanding private placement warrants [Member] Shares Underlying Outstanding Private Placement Warrants Collateral Held Collateral Held [Axis] Entity Small Business Entity Small Business Segment Reporting Information [Line Items] Cybersecurity Risk Management Processes for Assessing, Identifying, and Managing Threats [Text Block] Convertible Debenture Debt Disclosure [Text Block] Stockholders' Equity Note, Stock Split, Conversion Ratio Stock split, conversion ratio Treasury stock repurchased Treasury Stock, Shares, Acquired Preferred stock, a liquidation preference Preferred Stock Liquidating Preference Aggregate Purchase Price Of Common Stock Aggregate purchase price of common stock. Aggregate purchase price of common stock Issuance of restricted stock (in shares) Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures, Total Weighted-Average Exercise Price, Expired Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price CASH FLOWS FROM FINANCING ACTIVITIES: Net Cash Provided by (Used in) Financing Activities [Abstract] Weighted-Average Exercise Price, Balance Weighted-Average Exercise Price, Balance Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price Percentage of Warrants Issued With Holders Percentage of warrants issued with holders. Percentage of warrants issued with holders Exercise of warrants Exercise of warrants. Exercise of warrants Grant revenue. Grant Revenue Grant Revenue Policy [Text Block] State State and Local Jurisdiction [Member] Right of use assets and corresponding lease liabilities Right-of-Use Asset Obtained in Exchange for Operating Lease Liability Measurement Frequency Measurement Frequency [Domain] Less: valuation allowance Deferred Tax Assets, Valuation Allowance Level 3 Fair Value, Inputs, Level 3 [Member] Subsequent Events [Text Block] Subsequent Events Accrued interest Accrued Interest Current Accrued interest current. Cybersecurity Risk Management Positions or Committees Responsible [Flag] Accounts Payable, Current, Total Accounts payable Accounts Payable, Current Accrued clinical trial cost Accrued Clinical Trial Cost Current Accrued clinical trial cost current. Preferred stock liquidation asset value Preferred Stock Liquidation Asset Value Preferred stock liquidation asset value. Total costs and expenses Costs and Expenses Liabilities, Fair Value Disclosure Total Financial Liabilities Issuance date fair value Increase (Decrease) in Accrued Liabilities, Total Accrued expenses Increase (Decrease) in Accrued Liabilities President and Chief Executive Officer. President and Chief Executive Officer [Member]